← Back to Search

UPLIFT Program for Postpartum Depression (TePOP Trial)

N/A

Waitlist Available

Led By Gwen Latendresse, PhD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up time 1 = pre-intervention; t2 = immediately following week 9 of group intervention classes (post-intervention), t3= 2 months post-intervention; t4= 4 months post-intervention; t5 = 6 months post-intervention; t6 = 8 post-intervention

Awards & highlights

TePOP Trial Summary

This trial project is testing whether weekly videoconference groups can help reduce perinatal depressive symptoms for pregnant women of diverse backgrounds.

Eligible Conditions

Postpartum Depression

TePOP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ time 1 = pre-intervention; t2 = immediately following week 9 of group intervention classes (post-intervention), t3= 2 months post-intervention; t4= 4 months post-intervention; t5 = 6 months post-intervention; t6 = 8 post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~time 1 = pre-intervention; t2 = immediately following week 9 of group intervention classes (post-intervention), t3= 2 months post-intervention; t4= 4 months post-intervention; t5 = 6 months post-intervention; t6 = 8 post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and time 1 = pre-intervention; t2 = immediately following week 9 of group intervention classes (post-intervention), t3= 2 months post-intervention; t4= 4 months post-intervention; t5 = 6 months post-intervention; t6 = 8 post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Depressive Symptoms Over Time

Secondary outcome measures

Change in Anxiety Symptoms Over Time

TePOP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: UPLIFT ProgramExperimental Treatment1 Intervention

Weekly one-hour group sessions for 10 weeks facilitated by a mental health professional.

Group II: Pregnancy Skills GroupActive Control1 Intervention

Weekly one-hour group sessions for 10 weeks facilitated by a registered nurse.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

UPLIFT Program

2019

N/A

~100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor

1,099 Previous Clinical Trials

1,778,624 Total Patients Enrolled

1 Trials studying Postpartum Depression

120 Patients Enrolled for Postpartum Depression

National Institute of Nursing Research (NINR)NIH

580 Previous Clinical Trials

10,376,466 Total Patients Enrolled

2 Trials studying Postpartum Depression

407 Patients Enrolled for Postpartum Depression

Gwen Latendresse, PhDPrincipal Investigator - University of Utah

University of Utah

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been recruited for this investigation?

"Indeed, information present on clinicaltrials.gov indicates that this trial is actively recruiting participants. This medical research was originally posted on May 15th 2019 and edited most recently on February 28th 2022. A total of 192 patients are desired for the study across one primary site."

Answered by AI

Is this research still open to new participants?

"According to clinicaltrials.gov, this medical study is still in recruitment and has been since May 15th 2019. The details of the trial were last updated on February 28th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telehealth Group Intervention for Perinatal Depressive Symptoms

Gwen Latendresse 2019. "Telehealth Group Intervention for Perinatal Depressive Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03932760.